AVID BIOSERVICES INC (CDMO) Stock Price, Forecast & Analysis
NASDAQ:CDMO • US05368M1062
CDMO Key Statistics, Chart & Performance
The current stock price of CDMO is 12.49 USD. In the past month the price increased by 1.3%. In the past year, price increased by 85.86%.
CDMO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to CDMO. When comparing the yearly performance of all stocks, CDMO is one of the better performing stocks in the market, outperforming 91.92% of all stocks.
CDMO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CDMO. CDMO may be in some trouble as it scores bad on both profitability and health.
CDMO Financial Highlights
Over the last trailing twelve months CDMO reported a non-GAAP Earnings per Share(EPS) of -2.39. The EPS decreased by -1305.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47% | ||
| ROE | -339.34% | ||
| Debt/Equity | 3.58 |
CDMO Forecast & Estimates
11 analysts have analysed CDMO and the average price target is 12.75 USD. This implies a price increase of 2.08% is expected in the next year compared to the current price of 12.49.
For the next year, analysts expect an EPS growth of 86.15% and a revenue growth 17.28% for CDMO
CDMO Ownership
CDMO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.45 | 404.235B | ||
| AMGN | AMGEN INC | 16.68 | 204.477B | ||
| GILD | GILEAD SCIENCES INC | 16.97 | 189.501B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.94 | 119.327B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.83 | 83.747B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 50.5 | 43.95B | ||
| INSM | INSMED INC | N/A | 32.227B | ||
| NTRA | NATERA INC | N/A | 29.989B | ||
| BIIB | BIOGEN INC | 12.64 | 28.491B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.35 | 20.499B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CDMO
Company Profile
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. The company is headquartered in Tustin, California and currently employs 371 full-time employees. The firm provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.
Company Info
AVID BIOSERVICES INC
14191 Myford Road
Tustin CALIFORNIA 92780 US
CEO: Nicholas S. Green
Employees: 371
Phone: 17145086100
AVID BIOSERVICES INC / CDMO FAQ
What does AVID BIOSERVICES INC do?
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. The company is headquartered in Tustin, California and currently employs 371 full-time employees. The firm provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.
What is the stock price of AVID BIOSERVICES INC today?
The current stock price of CDMO is 12.49 USD. The price increased by 0.08% in the last trading session.
What is the dividend status of AVID BIOSERVICES INC?
CDMO does not pay a dividend.
How is the ChartMill rating for AVID BIOSERVICES INC?
CDMO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for CDMO stock?
AVID BIOSERVICES INC (CDMO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.39).
When does AVID BIOSERVICES INC (CDMO) report earnings?
AVID BIOSERVICES INC (CDMO) will report earnings on 2025-04-22, after the market close.